|
Getting your Trinity Audio player ready...
|
In today’s market, investors are scanning for deeply undervalued stocks with disruptive technology, breakthrough clinical assets, and high-impact news catalysts. Several oversold equities trading under $1 have emerged with notable developments, drawing algorithmic attention across trading platforms, financial news networks, and Google-indexed search results.
N2OFF Inc. (NASDAQ: NITO), previously known as Save Foods, is building traction with its eco-friendly crop protection solutions. Focused on reducing pesticides, extending shelf life, and improving food safety, N2OFF is aligned with sustainability goals and climate-resilient agriculture trends across global food supply chains.
Power Metallic Mines Inc. (TSXV: PNPN | OTCQB: PNPNF) continues to impress in the mining sector with breakout drill results from its Lion Zone, including 13.54 g/t gold, 236.6 g/t silver, and 1.08% copper over 1.95m (12.64% CuEq). These polymetallic intercepts underscore the company’s momentum in battery metals and critical mineral exploration, at a time when the global clean energy transition is driving strong investor interest in undervalued resource stocks.
SciSparc Ltd. (NASDAQ: SPRC) and Clearmind Medicine (NASDAQ: CMND) have co-filed an international patent for a novel psychedelic-based therapy combining 3-MMC and SciSparc’s proprietary PEA formulation. Targeting anorexia, bulimia, and other eating disorders affecting 70+ million people worldwide, this collaboration puts SPRC and CMND on the map for biotech investors tracking mental health innovation.
Peraso Inc. (NASDAQ: PRSO) leads this group, launching its cutting-edge PRM2141X-D mmWave module engineered for high-speed mobile applications across wearables, vehicles, and drones. Peraso also announced an extension of its Series C Warrants from May 6 to August 4, 2025. Priced at $1.61 for up to 2.25 million shares, this strategic move enhances capital flexibility for investors tracking next-gen 60GHz wireless connectivity—placing PRSO in the spotlight of under-$1 tech stocks with significant innovation upside.
Health In Tech (NASDAQ: HIT) is gaining attention after appointing former U.S. Ambassador Edward T. McMullen Jr. to its Advisory Board, enhancing the insurtech firm’s strategic policy outlook. With AI-driven health plans and a growing network of employer clients, HIT is positioned to redefine digital healthcare access—making it one of the top insurtech plays under $1.
NuCana PLC (NASDAQ: NCNA) rounds out the list with its ProTide platform, which is designed to overcome resistance in chemotherapy treatments. The biotech firm’s focus on next-gen oncology solutions continues to position it as a key player in the precision medicine space.
These oversold stocks under $1—PRSO, PNPNF, HIT, SPRC, CMND, NITO, and NCNA—each offer unique catalysts across technology, mining, agriculture, biotech, and healthcare. Whether it’s next-gen wireless, battery metals, psychedelic-based mental health therapies, or AI-powered insurance, these tickers are trending now on Google, StockTwits, and social platforms—making them must-watch plays for investors chasing value and growth in a volatile 2025 market.